nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Hydrocortisone—systemic lupus erythematosus	0.137	0.514	CrCtD
Medroxyprogesterone Acetate—Methylprednisolone—systemic lupus erythematosus	0.13	0.485	CrCtD
Medroxyprogesterone Acetate—breast cancer—Betamethasone—systemic lupus erythematosus	0.0935	0.5	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Dexamethasone—systemic lupus erythematosus	0.0935	0.5	CpDpCtD
Medroxyprogesterone Acetate—NR3C1—systemic lupus erythematosus	0.0905	1	CbGaD
Medroxyprogesterone Acetate—PGR—Betamethasone—systemic lupus erythematosus	0.0199	0.12	CbGbCtD
Medroxyprogesterone Acetate—SHBG—Hydrocortisone—systemic lupus erythematosus	0.0179	0.108	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Methylprednisolone—systemic lupus erythematosus	0.0157	0.0945	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Triamcinolone—systemic lupus erythematosus	0.0119	0.0716	CbGbCtD
Medroxyprogesterone Acetate—PGR—Dexamethasone—systemic lupus erythematosus	0.0116	0.07	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Betamethasone—systemic lupus erythematosus	0.0102	0.0614	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisolone—systemic lupus erythematosus	0.0101	0.0606	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Hydrocortisone—systemic lupus erythematosus	0.00953	0.0575	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—systemic lupus erythematosus	0.00949	0.0572	CbGbCtD
Medroxyprogesterone Acetate—Eplerenone—Hydrocortisone—systemic lupus erythematosus	0.00626	0.0298	CrCrCtD
Medroxyprogesterone Acetate—NR3C1—Dexamethasone—systemic lupus erythematosus	0.00593	0.0357	CbGbCtD
Medroxyprogesterone Acetate—Dydrogesterone—Hydrocortisone—systemic lupus erythematosus	0.00498	0.0237	CrCrCtD
Medroxyprogesterone Acetate—Drospirenone—Hydrocortisone—systemic lupus erythematosus	0.00498	0.0237	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Hydrocortisone—systemic lupus erythematosus	0.00474	0.0226	CrCrCtD
Medroxyprogesterone Acetate—Spironolactone—Hydrocortisone—systemic lupus erythematosus	0.00474	0.0226	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Dapsone—systemic lupus erythematosus	0.00471	0.0284	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Leflunomide—systemic lupus erythematosus	0.00461	0.0278	CbGbCtD
Medroxyprogesterone Acetate—Megestrol acetate—Hydrocortisone—systemic lupus erythematosus	0.00434	0.0206	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00408	0.0246	CbGbCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—systemic lupus erythematosus	0.00408	0.0194	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Hydrocortisone—systemic lupus erythematosus	0.004	0.019	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisolone—systemic lupus erythematosus	0.00398	0.019	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Methylprednisolone—systemic lupus erythematosus	0.00378	0.018	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Hydrocortisone—systemic lupus erythematosus	0.00372	0.0177	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Methylprednisolone—systemic lupus erythematosus	0.00351	0.0167	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Hydrocortisone—systemic lupus erythematosus	0.00348	0.0166	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Dexamethasone—systemic lupus erythematosus	0.00346	0.0164	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Betamethasone—systemic lupus erythematosus	0.00346	0.0164	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Hydrocortisone—systemic lupus erythematosus	0.00337	0.0161	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Prednisolone—systemic lupus erythematosus	0.00336	0.016	CrCrCtD
Medroxyprogesterone Acetate—CYP2C9—Dapsone—systemic lupus erythematosus	0.00329	0.0198	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortamate—Methylprednisolone—systemic lupus erythematosus	0.00329	0.0156	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00328	0.0198	CbGbCtD
Medroxyprogesterone Acetate—Prednicarbate—Hydrocortisone—systemic lupus erythematosus	0.00327	0.0156	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Methylprednisolone—systemic lupus erythematosus	0.00318	0.0151	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Prednisolone—systemic lupus erythematosus	0.00313	0.0149	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0031	0.0187	CbGbCtD
Medroxyprogesterone Acetate—Prednicarbate—Methylprednisolone—systemic lupus erythematosus	0.00309	0.0147	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Betamethasone—systemic lupus erythematosus	0.00304	0.0145	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Dexamethasone—systemic lupus erythematosus	0.00304	0.0145	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Hydrocortisone—systemic lupus erythematosus	0.00301	0.0143	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—systemic lupus erythematosus	0.003	0.0143	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Triamcinolone—systemic lupus erythematosus	0.00297	0.0141	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.00293	0.0139	CrCrCtD
Medroxyprogesterone Acetate—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.00293	0.0139	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Hydrocortisone—systemic lupus erythematosus	0.00293	0.0139	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisolone—systemic lupus erythematosus	0.00293	0.0139	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—systemic lupus erythematosus	0.00291	0.0138	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.00286	0.0136	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisolone—systemic lupus erythematosus	0.00284	0.0135	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—systemic lupus erythematosus	0.00282	0.0134	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Dexamethasone—systemic lupus erythematosus	0.00279	0.0133	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Betamethasone—systemic lupus erythematosus	0.00279	0.0133	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Methylprednisolone—systemic lupus erythematosus	0.00277	0.0132	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisolone—systemic lupus erythematosus	0.00275	0.0131	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Triamcinolone—systemic lupus erythematosus	0.00273	0.013	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Hydrocortisone—systemic lupus erythematosus	0.00272	0.013	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Betamethasone—systemic lupus erythematosus	0.00272	0.013	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Dexamethasone—systemic lupus erythematosus	0.00272	0.013	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Triamcinolone—systemic lupus erythematosus	0.00266	0.0127	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Methylprednisolone—systemic lupus erythematosus	0.00257	0.0122	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.00254	0.0121	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Hydrocortisone—systemic lupus erythematosus	0.00254	0.0121	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Prednisolone—systemic lupus erythematosus	0.00253	0.012	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Betamethasone—systemic lupus erythematosus	0.00253	0.012	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Dexamethasone—systemic lupus erythematosus	0.00253	0.012	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—systemic lupus erythematosus	0.00252	0.012	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Triamcinolone—systemic lupus erythematosus	0.00247	0.0118	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisolone—systemic lupus erythematosus	0.00246	0.0117	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Prednisolone—systemic lupus erythematosus	0.00246	0.0117	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.00246	0.0117	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.0024	0.0114	CrCrCtD
Medroxyprogesterone Acetate—CYP2C9—cardial valve—systemic lupus erythematosus	0.0024	0.185	CbGeAlD
Medroxyprogesterone Acetate—Methylprednisolone—Dexamethasone—systemic lupus erythematosus	0.00236	0.0112	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Betamethasone—systemic lupus erythematosus	0.00236	0.0112	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—systemic lupus erythematosus	0.00234	0.0112	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Triamcinolone—systemic lupus erythematosus	0.00231	0.011	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisolone—systemic lupus erythematosus	0.00229	0.0109	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Methylprednisolone—systemic lupus erythematosus	0.00226	0.0107	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Dexamethasone—systemic lupus erythematosus	0.00222	0.0106	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Betamethasone—systemic lupus erythematosus	0.00222	0.0106	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—systemic lupus erythematosus	0.00219	0.0104	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00219	0.0132	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortisone—Triamcinolone—systemic lupus erythematosus	0.00217	0.0103	CrCrCtD
Medroxyprogesterone Acetate—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00216	0.013	CbGbCtD
Medroxyprogesterone Acetate—Testosterone—Prednisolone—systemic lupus erythematosus	0.00214	0.0102	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisolone—systemic lupus erythematosus	0.00214	0.0102	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—systemic lupus erythematosus	0.00206	0.0098	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00204	0.0123	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisolone—systemic lupus erythematosus	0.00201	0.00956	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Dapsone—systemic lupus erythematosus	0.00191	0.0115	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00166	0.00999	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00166	0.00999	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00142	0.00857	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00142	0.00857	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0014	0.00846	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00133	0.00802	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—systemic lupus erythematosus	0.00132	0.00799	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00126	0.00757	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.000827	0.00499	CbGbCtD
Medroxyprogesterone Acetate—SHBG—blood plasma—systemic lupus erythematosus	0.000524	0.0403	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—urine—systemic lupus erythematosus	0.000521	0.0402	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—urine—systemic lupus erythematosus	0.000517	0.0399	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—nervous system—systemic lupus erythematosus	0.000491	0.0378	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—systemic lupus erythematosus	0.000473	0.0364	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—urine—systemic lupus erythematosus	0.000394	0.0304	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—nephron tubule—systemic lupus erythematosus	0.000359	0.0277	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cortex of kidney—systemic lupus erythematosus	0.000307	0.0237	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—blood plasma—systemic lupus erythematosus	0.000304	0.0234	CbGeAlD
Medroxyprogesterone Acetate—SHBG—connective tissue—systemic lupus erythematosus	0.000279	0.0215	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—blood plasma—systemic lupus erythematosus	0.000272	0.021	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood plasma—systemic lupus erythematosus	0.00027	0.0208	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—tendon—systemic lupus erythematosus	0.000255	0.0196	CbGeAlD
Medroxyprogesterone Acetate—PGR—connective tissue—systemic lupus erythematosus	0.000251	0.0193	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—bone marrow—systemic lupus erythematosus	0.000247	0.019	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lung—systemic lupus erythematosus	0.000224	0.0172	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—blood plasma—systemic lupus erythematosus	0.000206	0.0159	CbGeAlD
Medroxyprogesterone Acetate—AR—connective tissue—systemic lupus erythematosus	0.0002	0.0154	CbGeAlD
Medroxyprogesterone Acetate—ESR1—connective tissue—systemic lupus erythematosus	0.000196	0.0151	CbGeAlD
Medroxyprogesterone Acetate—SHBG—bone marrow—systemic lupus erythematosus	0.000186	0.0143	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—systemic lupus erythematosus	0.000184	0.0141	CbGeAlD
Medroxyprogesterone Acetate—AR—skin of body—systemic lupus erythematosus	0.000181	0.0139	CbGeAlD
Medroxyprogesterone Acetate—Cyproterone acetate—NR3C1—systemic lupus erythematosus	0.000176	0.148	CrCbGaD
Medroxyprogesterone Acetate—AR—kidney—systemic lupus erythematosus	0.00017	0.0131	CbGeAlD
Medroxyprogesterone Acetate—ESR1—kidney—systemic lupus erythematosus	0.000167	0.0129	CbGeAlD
Medroxyprogesterone Acetate—AR—cortex of kidney—systemic lupus erythematosus	0.000166	0.0128	CbGeAlD
Medroxyprogesterone Acetate—PGR—lung—systemic lupus erythematosus	0.000151	0.0117	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—systemic lupus erythematosus	0.00015	0.0116	CbGeAlD
Medroxyprogesterone Acetate—AR—lymphoid tissue—systemic lupus erythematosus	0.000146	0.0113	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—connective tissue—systemic lupus erythematosus	0.000145	0.0112	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—systemic lupus erythematosus	0.000144	0.0111	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nephron tubule—systemic lupus erythematosus	0.00014	0.0108	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—systemic lupus erythematosus	0.00014	0.0108	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—kidney—systemic lupus erythematosus	0.000138	0.0106	CbGeAlD
Medroxyprogesterone Acetate—AR—tendon—systemic lupus erythematosus	0.000137	0.0106	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—systemic lupus erythematosus	0.000135	0.0104	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—skin of body—systemic lupus erythematosus	0.000131	0.0101	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—kidney—systemic lupus erythematosus	0.000123	0.0095	CbGeAlD
Medroxyprogesterone Acetate—AR—lung—systemic lupus erythematosus	0.000121	0.0093	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cortex of kidney—systemic lupus erythematosus	0.00012	0.00926	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lung—systemic lupus erythematosus	0.000118	0.00913	CbGeAlD
Medroxyprogesterone Acetate—Prednicarbate—NR3C1—systemic lupus erythematosus	0.000114	0.0955	CrCbGaD
Medroxyprogesterone Acetate—AR—nervous system—systemic lupus erythematosus	0.000112	0.00861	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—systemic lupus erythematosus	0.00011	0.00845	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—systemic lupus erythematosus	0.000108	0.00829	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—systemic lupus erythematosus	0.000106	0.00816	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—systemic lupus erythematosus	0.000106	0.00814	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—tendon—systemic lupus erythematosus	9.96e-05	0.00767	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bone marrow—systemic lupus erythematosus	9.65e-05	0.00743	CbGeAlD
Medroxyprogesterone Acetate—Medrysone—NR3C1—systemic lupus erythematosus	9.53e-05	0.08	CrCbGaD
Medroxyprogesterone Acetate—CYP3A4—kidney—systemic lupus erythematosus	9.33e-05	0.00719	CbGeAlD
Medroxyprogesterone Acetate—Flurandrenolide—NR3C1—systemic lupus erythematosus	9.19e-05	0.0772	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortamate—NR3C1—systemic lupus erythematosus	8.89e-05	0.0747	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—NR3C1—systemic lupus erythematosus	8.75e-05	0.0735	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—lung—systemic lupus erythematosus	8.74e-05	0.00673	CbGeAlD
Medroxyprogesterone Acetate—Megestrol acetate—NR3C1—systemic lupus erythematosus	8.43e-05	0.0708	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—nervous system—systemic lupus erythematosus	8.09e-05	0.00624	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—systemic lupus erythematosus	7.79e-05	0.006	CbGeAlD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C1—systemic lupus erythematosus	6.93e-05	0.0582	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—NR3C1—systemic lupus erythematosus	6.68e-05	0.0561	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—NR3C1—systemic lupus erythematosus	6.46e-05	0.0543	CrCbGaD
Medroxyprogesterone Acetate—CYP3A4—nervous system—systemic lupus erythematosus	6.12e-05	0.00472	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—systemic lupus erythematosus	5.89e-05	0.00454	CbGeAlD
Medroxyprogesterone Acetate—Fluoxymesterone—NR3C1—systemic lupus erythematosus	5.73e-05	0.0481	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—NR3C1—systemic lupus erythematosus	5.24e-05	0.044	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—systemic lupus erythematosus	4.18e-05	0.0351	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—NR3C1—systemic lupus erythematosus	3.48e-05	0.0293	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—NR3C1—systemic lupus erythematosus	2.84e-05	0.0238	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—systemic lupus erythematosus	2.34e-05	0.0196	CrCbGaD
Medroxyprogesterone Acetate—Nausea—Leflunomide—systemic lupus erythematosus	1.38e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	1.38e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	1.38e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Hydrocortisone—systemic lupus erythematosus	1.38e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—systemic lupus erythematosus	1.37e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—systemic lupus erythematosus	1.37e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	1.37e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	1.37e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Betamethasone—systemic lupus erythematosus	1.37e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Dexamethasone—systemic lupus erythematosus	1.37e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	1.37e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	1.37e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	1.36e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Triamcinolone—systemic lupus erythematosus	1.36e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—systemic lupus erythematosus	1.36e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Methylprednisolone—systemic lupus erythematosus	1.36e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Dexamethasone—systemic lupus erythematosus	1.36e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Betamethasone—systemic lupus erythematosus	1.36e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ALB—systemic lupus erythematosus	1.36e-05	0.0114	CrCbGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—systemic lupus erythematosus	1.35e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Triamcinolone—systemic lupus erythematosus	1.35e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisolone—systemic lupus erythematosus	1.35e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	1.35e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—systemic lupus erythematosus	1.35e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—systemic lupus erythematosus	1.35e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Betamethasone—systemic lupus erythematosus	1.34e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Dexamethasone—systemic lupus erythematosus	1.34e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.34e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	1.34e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	1.34e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	1.34e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Betamethasone—systemic lupus erythematosus	1.34e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Prednisone—systemic lupus erythematosus	1.34e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CD80—systemic lupus erythematosus	1.34e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	1.34e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	1.34e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Betamethasone—systemic lupus erythematosus	1.33e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dexamethasone—systemic lupus erythematosus	1.33e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—systemic lupus erythematosus	1.33e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—HIST2H2AC—systemic lupus erythematosus	1.33e-05	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	1.33e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	1.33e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—systemic lupus erythematosus	1.32e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	1.32e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	1.32e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	1.32e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	1.32e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisone—systemic lupus erythematosus	1.31e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisone—systemic lupus erythematosus	1.31e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—systemic lupus erythematosus	1.31e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	1.31e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisone—systemic lupus erythematosus	1.31e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—systemic lupus erythematosus	1.3e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.3e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Betamethasone—systemic lupus erythematosus	1.3e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dexamethasone—systemic lupus erythematosus	1.3e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisolone—systemic lupus erythematosus	1.3e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—systemic lupus erythematosus	1.3e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Triamcinolone—systemic lupus erythematosus	1.3e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—CSK—systemic lupus erythematosus	1.3e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Methylprednisolone—systemic lupus erythematosus	1.3e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	1.29e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Cyclosporine—systemic lupus erythematosus	1.29e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.28e-05	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—systemic lupus erythematosus	1.28e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Dexamethasone—systemic lupus erythematosus	1.28e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Betamethasone—systemic lupus erythematosus	1.28e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Cyclosporine—systemic lupus erythematosus	1.27e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Hydrocortisone—systemic lupus erythematosus	1.27e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—systemic lupus erythematosus	1.27e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—systemic lupus erythematosus	1.26e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	1.26e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	1.26e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MTA2—systemic lupus erythematosus	1.26e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—Convulsion—Prednisone—systemic lupus erythematosus	1.26e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	1.26e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	1.26e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—systemic lupus erythematosus	1.26e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	1.25e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MTA2—systemic lupus erythematosus	1.24e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	1.24e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	1.24e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—systemic lupus erythematosus	1.24e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—systemic lupus erythematosus	1.24e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dexamethasone—systemic lupus erythematosus	1.24e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Betamethasone—systemic lupus erythematosus	1.24e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	1.23e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	1.23e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	1.23e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Dexamethasone—systemic lupus erythematosus	1.23e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Betamethasone—systemic lupus erythematosus	1.23e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Prednisone—systemic lupus erythematosus	1.23e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—systemic lupus erythematosus	1.23e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	1.22e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD247—systemic lupus erythematosus	1.22e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NAT2—systemic lupus erythematosus	1.22e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—Erythema—Methotrexate—systemic lupus erythematosus	1.22e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—systemic lupus erythematosus	1.22e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisolone—systemic lupus erythematosus	1.21e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	1.2e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Betamethasone—systemic lupus erythematosus	1.2e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	1.2e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Triamcinolone—systemic lupus erythematosus	1.2e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methylprednisolone—systemic lupus erythematosus	1.19e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—systemic lupus erythematosus	1.19e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Cyclosporine—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Betamethasone—systemic lupus erythematosus	1.19e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—NCF2—systemic lupus erythematosus	1.19e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Prednisone—systemic lupus erythematosus	1.18e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dexamethasone—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Betamethasone—systemic lupus erythematosus	1.18e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	1.18e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.17e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Prednisone—systemic lupus erythematosus	1.17e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—systemic lupus erythematosus	1.17e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—systemic lupus erythematosus	1.16e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	1.16e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—systemic lupus erythematosus	1.16e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—systemic lupus erythematosus	1.15e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Hydrocortisone—systemic lupus erythematosus	1.15e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Cyclosporine—systemic lupus erythematosus	1.14e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.13e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Cyclosporine—systemic lupus erythematosus	1.13e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Prednisone—systemic lupus erythematosus	1.13e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Cyclosporine—systemic lupus erythematosus	1.13e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Hydrocortisone—systemic lupus erythematosus	1.13e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.13e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	1.13e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—TYK2—systemic lupus erythematosus	1.13e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Cyclosporine—systemic lupus erythematosus	1.13e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—systemic lupus erythematosus	1.13e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	1.13e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Betamethasone—systemic lupus erythematosus	1.13e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	1.12e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	1.12e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	1.12e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	1.12e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	1.11e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	1.11e-05	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	1.11e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	1.11e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	1.11e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.1e-05	0.000993	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Mycophenolate mofetil—systemic lupus erythematosus	1.1e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—systemic lupus erythematosus	1.1e-05	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.1e-05	0.00099	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.1e-05	0.00099	CbGpPWpGaD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—systemic lupus erythematosus	1.09e-05	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	1.09e-05	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Dexamethasone—systemic lupus erythematosus	1.09e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Betamethasone—systemic lupus erythematosus	1.09e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	1.08e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisolone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Triamcinolone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Betamethasone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Betamethasone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methylprednisolone—systemic lupus erythematosus	1.08e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—systemic lupus erythematosus	1.08e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.08e-05	0.000971	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SNRPB—systemic lupus erythematosus	1.07e-05	0.000968	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.07e-05	0.000968	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Cyclosporine—systemic lupus erythematosus	1.07e-05	0.000198	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—systemic lupus erythematosus	1.07e-05	0.000198	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Triamcinolone—systemic lupus erythematosus	1.07e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methylprednisolone—systemic lupus erythematosus	1.06e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.06e-05	0.000957	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Hydrocortisone—systemic lupus erythematosus	1.06e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—systemic lupus erythematosus	1.06e-05	0.000195	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—systemic lupus erythematosus	1.05e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	1.04e-05	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.04e-05	0.000941	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.04e-05	0.000937	CbGpPWpGaD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—systemic lupus erythematosus	1.04e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—systemic lupus erythematosus	1.04e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—systemic lupus erythematosus	1.04e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—systemic lupus erythematosus	1.03e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisolone—systemic lupus erythematosus	1.03e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisolone—systemic lupus erythematosus	1.03e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	1.03e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	1.03e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	1.03e-05	0.000927	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Prednisone—systemic lupus erythematosus	1.03e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisolone—systemic lupus erythematosus	1.03e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—systemic lupus erythematosus	1.02e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TLR9—systemic lupus erythematosus	1.02e-05	0.00092	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Prednisone—systemic lupus erythematosus	1.02e-05	0.000188	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Hydrocortisone—systemic lupus erythematosus	1.02e-05	0.000188	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.02e-05	0.000917	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	1.01e-05	0.000913	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Hydrocortisone—systemic lupus erythematosus	1.01e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	1.01e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—systemic lupus erythematosus	1e-05	0.000186	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Hydrocortisone—systemic lupus erythematosus	1e-05	0.000185	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Triamcinolone—systemic lupus erythematosus	9.96e-06	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	9.94e-06	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methylprednisolone—systemic lupus erythematosus	9.93e-06	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	9.93e-06	0.000897	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CDKN1A—systemic lupus erythematosus	9.89e-06	0.000893	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Methotrexate—systemic lupus erythematosus	9.88e-06	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—P2RY12—systemic lupus erythematosus	9.87e-06	0.000891	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—systemic lupus erythematosus	9.8e-06	0.000182	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dexamethasone—systemic lupus erythematosus	9.8e-06	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Betamethasone—systemic lupus erythematosus	9.8e-06	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—systemic lupus erythematosus	9.75e-06	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	9.73e-06	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	9.73e-06	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisolone—systemic lupus erythematosus	9.72e-06	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.68e-06	0.000874	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Dexamethasone—systemic lupus erythematosus	9.67e-06	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Betamethasone—systemic lupus erythematosus	9.67e-06	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—systemic lupus erythematosus	9.66e-06	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	9.64e-06	0.00087	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	9.61e-06	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	9.6e-06	0.000867	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9.58e-06	0.000865	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Triamcinolone—systemic lupus erythematosus	9.57e-06	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.55e-06	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Hydrocortisone—systemic lupus erythematosus	9.5e-06	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Triamcinolone—systemic lupus erythematosus	9.49e-06	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	9.49e-06	0.000857	CbGpPWpGaD
Medroxyprogesterone Acetate—Dermatitis—Triamcinolone—systemic lupus erythematosus	9.48e-06	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—systemic lupus erythematosus	9.48e-06	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methylprednisolone—systemic lupus erythematosus	9.47e-06	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	9.46e-06	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisone—systemic lupus erythematosus	9.45e-06	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Triamcinolone—systemic lupus erythematosus	9.43e-06	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—systemic lupus erythematosus	9.41e-06	0.00085	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Methylprednisolone—systemic lupus erythematosus	9.41e-06	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—systemic lupus erythematosus	9.4e-06	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—systemic lupus erythematosus	9.4e-06	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.35e-06	0.000173	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.35e-06	0.000173	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	9.32e-06	0.000841	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—JUNB—systemic lupus erythematosus	9.31e-06	0.00084	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—systemic lupus erythematosus	9.29e-06	0.000172	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	9.14e-06	0.000825	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	9.12e-06	0.000823	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	9.09e-06	0.00082	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CSK—systemic lupus erythematosus	9.08e-06	0.00082	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.06e-06	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Betamethasone—systemic lupus erythematosus	9.03e-06	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Dexamethasone—systemic lupus erythematosus	9.03e-06	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—systemic lupus erythematosus	8.99e-06	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Triamcinolone—systemic lupus erythematosus	8.94e-06	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	8.94e-06	0.000807	CbGpPWpGaD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—systemic lupus erythematosus	8.93e-06	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methylprednisolone—systemic lupus erythematosus	8.92e-06	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—systemic lupus erythematosus	8.91e-06	0.000805	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—systemic lupus erythematosus	8.86e-06	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	8.86e-06	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—systemic lupus erythematosus	8.84e-06	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—systemic lupus erythematosus	8.77e-06	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—systemic lupus erythematosus	8.75e-06	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PPARG—systemic lupus erythematosus	8.73e-06	0.000788	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.71e-06	0.000786	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	8.7e-06	0.000786	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Betamethasone—systemic lupus erythematosus	8.69e-06	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dexamethasone—systemic lupus erythematosus	8.69e-06	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—systemic lupus erythematosus	8.64e-06	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.64e-06	0.00078	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Betamethasone—systemic lupus erythematosus	8.61e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dexamethasone—systemic lupus erythematosus	8.61e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	8.61e-06	0.000778	CbGpPWpGaD
Medroxyprogesterone Acetate—Dermatitis—Betamethasone—systemic lupus erythematosus	8.61e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.61e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.58e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—PRL—systemic lupus erythematosus	8.57e-06	0.000774	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—systemic lupus erythematosus	8.57e-06	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Dexamethasone—systemic lupus erythematosus	8.56e-06	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Betamethasone—systemic lupus erythematosus	8.56e-06	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Prednisone—systemic lupus erythematosus	8.54e-06	0.000158	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—TNFSF13—systemic lupus erythematosus	8.53e-06	0.00077	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	8.48e-06	0.000765	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	8.45e-06	0.000763	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	8.45e-06	0.000762	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Prednisone—systemic lupus erythematosus	8.42e-06	0.000156	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—TNFSF13—systemic lupus erythematosus	8.4e-06	0.000759	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	8.32e-06	0.000751	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NCF2—systemic lupus erythematosus	8.31e-06	0.00075	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SNRPB—systemic lupus erythematosus	8.26e-06	0.000746	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LYN—systemic lupus erythematosus	8.25e-06	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—systemic lupus erythematosus	8.19e-06	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—systemic lupus erythematosus	8.18e-06	0.000739	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—systemic lupus erythematosus	8.14e-06	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SNRPB—systemic lupus erythematosus	8.14e-06	0.000735	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	8.13e-06	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.13e-06	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Betamethasone—systemic lupus erythematosus	8.11e-06	0.00015	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dexamethasone—systemic lupus erythematosus	8.11e-06	0.00015	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SH2B3—systemic lupus erythematosus	8.09e-06	0.000731	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TLR9—systemic lupus erythematosus	8.04e-06	0.000726	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	8.03e-06	0.000725	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	8e-06	0.000722	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.93e-06	0.000716	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—JUNB—systemic lupus erythematosus	7.91e-06	0.000714	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—systemic lupus erythematosus	7.9e-06	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisone—systemic lupus erythematosus	7.87e-06	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—systemic lupus erythematosus	7.86e-06	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—systemic lupus erythematosus	7.86e-06	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALB—systemic lupus erythematosus	7.85e-06	0.000709	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.78e-06	0.000703	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	7.7e-06	0.000695	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	7.65e-06	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—systemic lupus erythematosus	7.64e-06	0.00069	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.62e-06	0.000688	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Prednisone—systemic lupus erythematosus	7.56e-06	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	7.53e-06	0.00068	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—NOS3—systemic lupus erythematosus	7.51e-06	0.000678	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Prednisone—systemic lupus erythematosus	7.5e-06	0.000139	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—systemic lupus erythematosus	7.49e-06	0.000139	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisone—systemic lupus erythematosus	7.45e-06	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7.4e-06	0.000668	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.38e-06	0.000666	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.35e-06	0.000664	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.33e-06	0.000136	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CSK—systemic lupus erythematosus	7.16e-06	0.000647	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—systemic lupus erythematosus	7.13e-06	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisone—systemic lupus erythematosus	7.07e-06	0.000131	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—systemic lupus erythematosus	7.03e-06	0.00013	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.02e-06	0.000634	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	7.02e-06	0.000634	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—RXRA—systemic lupus erythematosus	6.93e-06	0.000626	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	6.92e-06	0.000625	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	6.89e-06	0.000622	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—systemic lupus erythematosus	6.87e-06	0.00062	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—JAK1—systemic lupus erythematosus	6.86e-06	0.000619	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—RXRA—systemic lupus erythematosus	6.83e-06	0.000617	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—systemic lupus erythematosus	6.8e-06	0.000126	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.65e-06	0.000601	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.64e-06	0.000599	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	6.63e-06	0.000599	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	6.6e-06	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—systemic lupus erythematosus	6.57e-06	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NCF2—systemic lupus erythematosus	6.55e-06	0.000591	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	6.53e-06	0.00059	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JUNB—systemic lupus erythematosus	6.52e-06	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LYN—systemic lupus erythematosus	6.51e-06	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CCR5—systemic lupus erythematosus	6.5e-06	0.000587	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.38e-06	0.000576	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.34e-06	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—systemic lupus erythematosus	6.32e-06	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—VDR—systemic lupus erythematosus	6.28e-06	0.000567	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Methotrexate—systemic lupus erythematosus	6.27e-06	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—systemic lupus erythematosus	6.26e-06	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methotrexate—systemic lupus erythematosus	6.23e-06	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.19e-06	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—systemic lupus erythematosus	6.16e-06	0.000557	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.11e-06	0.000551	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	6.03e-06	0.000544	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—JUNB—systemic lupus erythematosus	6.02e-06	0.000544	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRL—systemic lupus erythematosus	6e-06	0.000542	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Methotrexate—systemic lupus erythematosus	5.91e-06	0.000109	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—EP300—systemic lupus erythematosus	5.71e-06	0.000516	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.7e-06	0.000515	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR3C1—systemic lupus erythematosus	5.65e-06	0.00051	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—systemic lupus erythematosus	5.52e-06	0.000499	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD80—systemic lupus erythematosus	5.35e-06	0.000483	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.33e-06	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	5.33e-06	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RXRA—systemic lupus erythematosus	5.28e-06	0.000477	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	5.25e-06	0.000474	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.24e-06	0.000473	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JUNB—systemic lupus erythematosus	5.14e-06	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.88e-06	0.000441	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JAK1—systemic lupus erythematosus	4.8e-06	0.000434	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—VDR—systemic lupus erythematosus	4.78e-06	0.000432	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRL—systemic lupus erythematosus	4.74e-06	0.000428	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.72e-06	0.000426	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—JUNB—systemic lupus erythematosus	4.64e-06	0.000419	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—JUNB—systemic lupus erythematosus	4.57e-06	0.000413	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.57e-06	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR5—systemic lupus erythematosus	4.55e-06	0.000411	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TYK2—systemic lupus erythematosus	4.51e-06	0.000407	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.48e-06	0.000405	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—C3—systemic lupus erythematosus	4.45e-06	0.000401	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS3—systemic lupus erythematosus	4.43e-06	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PPARG—systemic lupus erythematosus	4.38e-06	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.31e-06	0.000389	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PPARG—systemic lupus erythematosus	4.31e-06	0.000389	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.31e-06	0.000389	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR3C1—systemic lupus erythematosus	4.3e-06	0.000389	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CSK—systemic lupus erythematosus	4.2e-06	0.00038	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD4—systemic lupus erythematosus	4.08e-06	0.000368	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RXRA—systemic lupus erythematosus	4.07e-06	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—systemic lupus erythematosus	4.05e-06	0.000366	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RXRA—systemic lupus erythematosus	4.01e-06	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—F2—systemic lupus erythematosus	3.9e-06	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—systemic lupus erythematosus	3.88e-06	0.00035	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.85e-06	0.000347	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1B—systemic lupus erythematosus	3.84e-06	0.000346	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LYN—systemic lupus erythematosus	3.82e-06	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JAK1—systemic lupus erythematosus	3.79e-06	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.75e-06	0.000338	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CD80—systemic lupus erythematosus	3.74e-06	0.000338	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NOS3—systemic lupus erythematosus	3.71e-06	0.000335	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—VDR—systemic lupus erythematosus	3.68e-06	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—VDR—systemic lupus erythematosus	3.63e-06	0.000327	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR5—systemic lupus erythematosus	3.59e-06	0.000324	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1A—systemic lupus erythematosus	3.54e-06	0.00032	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.54e-06	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.51e-06	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—C3—systemic lupus erythematosus	3.51e-06	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—systemic lupus erythematosus	3.48e-06	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	3.43e-06	0.000309	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—systemic lupus erythematosus	3.39e-06	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EP300—systemic lupus erythematosus	3.37e-06	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—systemic lupus erythematosus	3.33e-06	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR3C1—systemic lupus erythematosus	3.32e-06	0.000299	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TYK2—systemic lupus erythematosus	3.16e-06	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.1e-06	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—F2—systemic lupus erythematosus	3.08e-06	0.000278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.07e-06	0.000278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.02e-06	0.000272	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CD80—systemic lupus erythematosus	2.95e-06	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—systemic lupus erythematosus	2.93e-06	0.000264	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.87e-06	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—EP300—systemic lupus erythematosus	2.82e-06	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	2.79e-06	0.000252	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRL—systemic lupus erythematosus	2.78e-06	0.000251	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—systemic lupus erythematosus	2.74e-06	0.000248	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.72e-06	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.69e-06	0.000243	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—systemic lupus erythematosus	2.63e-06	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—systemic lupus erythematosus	2.57e-06	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—systemic lupus erythematosus	2.53e-06	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TYK2—systemic lupus erythematosus	2.49e-06	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.49e-06	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.48e-06	0.000224	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.45e-06	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—systemic lupus erythematosus	2.45e-06	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EP300—systemic lupus erythematosus	2.36e-06	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.23e-06	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.22e-06	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.22e-06	0.0002	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—systemic lupus erythematosus	2.21e-06	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.14e-06	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.12e-06	0.000191	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.11e-06	0.00019	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.08e-06	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—systemic lupus erythematosus	2.07e-06	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—C3—systemic lupus erythematosus	2.06e-06	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.05e-06	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.99e-06	0.00018	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.96e-06	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.96e-06	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.92e-06	0.000173	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-06	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.84e-06	0.000166	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2—systemic lupus erythematosus	1.81e-06	0.000163	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.78e-06	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.76e-06	0.000159	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.74e-06	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.73e-06	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.62e-06	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.61e-06	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.56e-06	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—systemic lupus erythematosus	1.55e-06	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.46e-06	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.45e-06	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.44e-06	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.24e-06	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.22e-06	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	1.21e-06	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.15e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.15e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.09e-06	9.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.09e-06	9.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.04e-06	9.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.03e-06	9.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.03e-06	9.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	9.87e-07	8.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	9.54e-07	8.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.5e-07	8.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	8.87e-07	8.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	8.49e-07	7.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	7.93e-07	7.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	7.76e-07	7.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—systemic lupus erythematosus	7.15e-07	6.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.51e-07	5.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	6.46e-07	5.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.85e-07	5.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.6e-07	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.12e-07	4.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.26e-07	3.84e-05	CbGpPWpGaD
